337 related items for PubMed ID: 27064036
1. Corticosteroid Therapy Might be Associated with the Development of Coronary Aneurysm in Children with Kawasaki Disease.
Zhao CN, Du ZD, Gao LL.
Chin Med J (Engl); 2016 Apr 20; 129(8):922-8. PubMed ID: 27064036
[Abstract] [Full Text] [Related]
2. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
Postgrad Med; 2018 May 20; 130(4):442-447. PubMed ID: 29745742
[Abstract] [Full Text] [Related]
3. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
Pediatr Infect Dis J; 2018 Oct 20; 37(10):976-980. PubMed ID: 29461447
[Abstract] [Full Text] [Related]
4. Corticosteroid administration for patients with coronary artery aneurysms after Kawasaki disease may be associated with impaired regression.
Millar K, Manlhiot C, Yeung RS, Somji Z, McCrindle BW.
Int J Cardiol; 2012 Jan 12; 154(1):9-13. PubMed ID: 20851480
[Abstract] [Full Text] [Related]
5. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
Turk J Pediatr; 2019 Jan 12; 61(5):648-656. PubMed ID: 32104995
[Abstract] [Full Text] [Related]
6. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
[Abstract] [Full Text] [Related]
7. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED.
Pediatr Cardiol; 2003 Mar 21; 24(2):122-6. PubMed ID: 12457252
[Abstract] [Full Text] [Related]
8. Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis.
Chen S, Dong Y, Kiuchi MG, Wang J, Li R, Ling Z, Zhou T, Wang Z, Martinek M, Pürerfellner H, Liu S, Krucoff MW.
JAMA Pediatr; 2016 Dec 01; 170(12):1156-1163. PubMed ID: 27749951
[Abstract] [Full Text] [Related]
9. [Risk factors for coronary artery lesions in children with Kawasaki disease].
Li Y, Wang XM, Liu YL, Shi K, Yang YF, Guo YH.
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec 01; 14(12):938-41. PubMed ID: 23234782
[Abstract] [Full Text] [Related]
10. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
Chen J, Liu P, Hu W, Xu Y, Deng J.
Clin Rheumatol; 2021 Oct 01; 40(10):4191-4197. PubMed ID: 34059986
[Abstract] [Full Text] [Related]
11. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis.
Friedman KG, Gauvreau K, Baker A, Son MB, Sundel R, Dionne A, Giorgio T, De Ferranti S, Newburger JW.
Arch Dis Child; 2021 Mar 01; 106(3):247-252. PubMed ID: 32943389
[Abstract] [Full Text] [Related]
12. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, Pongprot Y, Sittiwangkul R.
Paediatr Int Child Health; 2018 Aug 01; 38(3):209-212. PubMed ID: 29768976
[Abstract] [Full Text] [Related]
13. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin.
Kibata T, Suzuki Y, Hasegawa S, Matsushige T, Kusuda T, Hoshide M, Takahashi K, Okada S, Wakiguchi H, Moriwake T, Uchida M, Ohbuchi N, Iwai T, Hasegawa M, Ichihara K, Yashiro M, Makino N, Nakamura Y, Ohga S.
Int J Cardiol; 2016 Jul 01; 214():209-15. PubMed ID: 27070994
[Abstract] [Full Text] [Related]
14. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
Li W, He X, Zhang L, Wang Z, Wang Y, Lin H, Yuan J, Xie X, Qin Y, Huang P.
Cardiovasc Ther; 2021 Jul 01; 2021():6660407. PubMed ID: 34239607
[Abstract] [Full Text] [Related]
15. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
Pediatrics; 2004 Dec 01; 114(6):e689-93. PubMed ID: 15545617
[Abstract] [Full Text] [Related]
16. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
Wang JR, Zhao HZ, Chang LJ, Xu X, Gao Y, Li M, Kong QY, Wang MM, Zhao CF.
Eur J Pediatr; 2023 Oct 01; 182(10):4399-4406. PubMed ID: 37480545
[Abstract] [Full Text] [Related]
17. Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease.
Wu Y, Wang S, Zhou Y, Yang Y, Li S, Yin W, Ding Y.
PLoS One; 2023 Oct 01; 18(10):e0292653. PubMed ID: 37824465
[Abstract] [Full Text] [Related]
18. Development of coronary artery lesions in indolent Kawasaki disease following initial spontaneous defervescence: a retrospective cohort study.
Takahashi T, Sakakibara H, Morikawa Y, Miura M.
Pediatr Rheumatol Online J; 2015 Nov 04; 13(1):44. PubMed ID: 26530040
[Abstract] [Full Text] [Related]
19. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
J Int Med Res; 2024 May 04; 52(5):3000605241252115. PubMed ID: 38713460
[Abstract] [Full Text] [Related]
20. Outcomes in Kawasaki disease patients with coronary artery abnormalities at admission.
Ae R, Abrams JY, Maddox RA, Schonberger LB, Nakamura Y, Kuwabara M, Makino N, Matsubara Y, Matsubara D, Kosami K, Sasahara T, Belay ED.
Am Heart J; 2020 Jul 04; 225():120-128. PubMed ID: 32497905
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
